Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern

to connected objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: International Journal of Molecular Sciences 23.12 (2022): 6830.

Event: Veröffentlichung

(where): Erlangen

(who): Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

(when): 2022

Creator: Setz, Christian
Große, Maximilian
Auth, Janina
Fröba, Maria
Rauch, Pia
Bausch, Alexander
Wright, Matthew
Schubert, Ulrich

DOI: 10.3390/ijms23126830

URN: urn:nbn:de:bvb:29-opus4-206223

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 25.03.2025, 1:47 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Setz, Christian
Große, Maximilian
Auth, Janina
Fröba, Maria
Rauch, Pia
Bausch, Alexander
Wright, Matthew
Schubert, Ulrich
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

Time of origin

2022

Other Objects (12)

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta

Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta

Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination

Body temperature-controlled antiviral response and SARS-CoV-2 replication

Antiviral molecules for the intervention of SARS-CoV-2 infections

Lack of antiviral activity of darunavir against SARS-CoV-2

Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants

Peptide variants of a SARS-CoV-2 neutralizing protein

Cross-Reactivity of IgG Antibodies and Virus Neutralization in mRNAVaccinated People Against Wild- Type SARS-CoV-2 and the Five Most Common SARS-CoV-2 Variants of Concern

Towards cell-permeable hepatitis B virus core protein variants as potential antiviral agents

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta

Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta

Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination

Body temperature-controlled antiviral response and SARS-CoV-2 replication

Antiviral molecules for the intervention of SARS-CoV-2 infections

Lack of antiviral activity of darunavir against SARS-CoV-2

Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants

Peptide variants of a SARS-CoV-2 neutralizing protein

Cross-Reactivity of IgG Antibodies and Virus Neutralization in mRNAVaccinated People Against Wild- Type SARS-CoV-2 and the Five Most Common SARS-CoV-2 Variants of Concern

Towards cell-permeable hepatitis B virus core protein variants as potential antiviral agents

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta

Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta

Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination

Body temperature-controlled antiviral response and SARS-CoV-2 replication

Antiviral molecules for the intervention of SARS-CoV-2 infections

Lack of antiviral activity of darunavir against SARS-CoV-2

Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants

Peptide variants of a SARS-CoV-2 neutralizing protein

Cross-Reactivity of IgG Antibodies and Virus Neutralization in mRNAVaccinated People Against Wild- Type SARS-CoV-2 and the Five Most Common SARS-CoV-2 Variants of Concern

Towards cell-permeable hepatitis B virus core protein variants as potential antiviral agents

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta

Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta

Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination

Body temperature-controlled antiviral response and SARS-CoV-2 replication

Antiviral molecules for the intervention of SARS-CoV-2 infections

Lack of antiviral activity of darunavir against SARS-CoV-2

Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants

Peptide variants of a SARS-CoV-2 neutralizing protein

Cross-Reactivity of IgG Antibodies and Virus Neutralization in mRNAVaccinated People Against Wild- Type SARS-CoV-2 and the Five Most Common SARS-CoV-2 Variants of Concern

Towards cell-permeable hepatitis B virus core protein variants as potential antiviral agents

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta

Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta

Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination

Body temperature-controlled antiviral response and SARS-CoV-2 replication

Antiviral molecules for the intervention of SARS-CoV-2 infections

Lack of antiviral activity of darunavir against SARS-CoV-2

Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants

Peptide variants of a SARS-CoV-2 neutralizing protein

Cross-Reactivity of IgG Antibodies and Virus Neutralization in mRNAVaccinated People Against Wild- Type SARS-CoV-2 and the Five Most Common SARS-CoV-2 Variants of Concern

Towards cell-permeable hepatitis B virus core protein variants as potential antiviral agents

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta

Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta

Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination

Body temperature-controlled antiviral response and SARS-CoV-2 replication

Antiviral molecules for the intervention of SARS-CoV-2 infections

Lack of antiviral activity of darunavir against SARS-CoV-2

Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants

Peptide variants of a SARS-CoV-2 neutralizing protein

Cross-Reactivity of IgG Antibodies and Virus Neutralization in mRNAVaccinated People Against Wild- Type SARS-CoV-2 and the Five Most Common SARS-CoV-2 Variants of Concern

Towards cell-permeable hepatitis B virus core protein variants as potential antiviral agents

Related objects

Reset password